Trials / Active Not Recruiting
Active Not RecruitingNCT06019533
A Trial on Contraceptive Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles
A Multicentre, Single Arm Trial on Contraceptive Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- Chemo Research · Industry
- Sex
- Female
- Age
- 15 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Multicentre, single arm phase III trial to assess the pearl index of LVDS. The trial lasts 13 cycles.The assessments include (but are not limited to) recording demographic data, pregnancy tests, gynaecological examinations, laboratory tests and a quality of life questionnaire. Adolescents will undergo DXA scans to measure bone mineral density (at selected sites only). The women will be provided with an e-diary app for their smartphone, to record IP use and vaginal bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | LVDS | Levonorgestrel Vaginal Delivery System |
Timeline
- Start date
- 2023-08-09
- Primary completion
- 2025-04-30
- Completion
- 2026-04-30
- First posted
- 2023-08-31
- Last updated
- 2025-02-21
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06019533. Inclusion in this directory is not an endorsement.